Breathing Room: Hopeful Momentum in Saudi Respiratory Care Market

Forecasts in the Saudi devices segment also point to steady expansion, though at a different pace depending on the lens used. A separate outlook published on Vocal Media projects Saudi Arabia’s respiratory devices market will reach USD 336.5 million by 2034, with a CAGR of 5.15% during 2026–2034. Beyond topline growth, the same source frames AI as an operational driver, describing smart diagnostics and real-time monitoring use cases in clinics and intensive care. It also notes a December 3, 2024 partnership where Bedfont Scientific Limited partnered with Tebaba Medical Services to distribute NObreath FeNO and Gastrolyzer devices in the Middle East, positioning exhaled-breath testing as part of asthma diagnosis and management in the region.

From ICU Demand to Home Monitoring: What’s Changing

A key theme across sources is the move from episodic hospital intervention to continuous management, especially at home. Mordor Intelligence’s global respiratory devices report says hospitals commanded 56.23% share of the respiratory devices market size in 2025, while home settings are expanding at an 11.7% CAGR during 2026–2031. It also reports therapeutic devices held 47.56% of 2025 market share globally, and that COPD retained 35.53% of 2025 revenue, while infectious diseases is expanding at a 10.85% CAGR. Those are global figures, but they help explain why Saudi stakeholders are focusing on connected care: Mobility Foresights describes remote respiratory monitoring platforms that track oxygen saturation, breathing patterns, and device usage in real time, reducing hospital visits and improving adherence while supporting at-home treatment through tele-respiratory services.

Technology language is increasingly central to how the market is described. Mobility Foresights states AI-driven respiratory devices that analyze breathing patterns, predict exacerbations, and optimize therapy settings are becoming increasingly common in Saudi Arabia. It also highlights growing use of high-flow oxygen therapy devices, describing them as emerging as a preferred option for patients with acute respiratory distress or hypoxemia, and notes deployments in ICUs, emergency departments, and step-down units. The Vocal Media outlook adds detail on how AI is positioned in care workflows, including wearable monitoring for oxygen levels and alerts, and ventilator optimization logic in ICUs that adjusts pressure and oxygen delivery based on patient mechanics, aimed at reducing over-ventilation risk and improving outcomes.

Saudi Arabia’s trajectory sits inside a much larger global expansion in respiratory and sleep-related device categories, which can influence product pipelines and vendor priorities. Precedence Research estimates the global respiratory care devices market was USD 26.76 billion in 2025, accounted for USD 29.16 billion in 2026, and is expected to reach around USD 62.64 billion by 2035, expanding at a CAGR of 8.88% from 2026 to 2035; it also reports North America held 42.63% share in 2025. Verified Market Reports values the global sleep and respiratory care devices market at USD 30.30 billion in 2024 and estimates it will reach USD 49.23 billion by 2033, growing at a CAGR of 6.09% from 2026 to 2033. For Saudi decision-makers, the practical takeaway is not the global totals, but the direction: more connected devices, more home use, and more emphasis on monitoring and therapy optimization.